Based on the prognostic significance of SIRT6 expression in osteosarcoma patients, especially in the patients who received adjuvant chemotherapy, we evaluated the effects of SIRT6 expression on the anti-tumor activity of doxorubicin in osteosarcoma cells. Here, SIRT6 is linked to osteosarcoma.